Put Options

14 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 14, 2024

BUY
$209.01 - $232.56 $1.36 Million - $1.51 Million
6,500 New
6,500 $1.42 Million
Q2 2023

Aug 11, 2023

SELL
$211.93 - $241.33 $2.08 Million - $2.37 Million
-9,800 Reduced 56.0%
7,700 $1.86 Million
Q1 2023

May 12, 2023

BUY
$213.32 - $257.83 $1.77 Million - $2.14 Million
8,300 Added 90.22%
17,500 $4.01 Million
Q4 2022

Feb 10, 2023

BUY
$203.72 - $248.97 $733,392 - $896,292
3,600 Added 64.29%
9,200 $2.17 Million
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $327,696 - $419,504
1,600 Added 40.0%
5,600 $1.15 Million
Q2 2022

Aug 12, 2022

BUY
$213.86 - $277.87 $427,720 - $555,740
2,000 Added 100.0%
4,000 $937,000
Q1 2022

May 13, 2022

SELL
$259.82 - $298.18 $5.9 Million - $6.77 Million
-22,700 Reduced 91.9%
2,000 $527,000
Q4 2021

Feb 11, 2022

BUY
$271.6 - $314.21 $4.81 Million - $5.56 Million
17,700 Added 252.86%
24,700 $7.76 Million
Q3 2021

Nov 12, 2021

BUY
$274.82 - $308.34 $1.32 Million - $1.48 Million
4,800 Added 218.18%
7,000 $1.97 Million
Q2 2021

Aug 13, 2021

BUY
$251.87 - $278.14 $176,309 - $194,698
700 Added 46.67%
2,200 $607,000
Q1 2021

May 14, 2021

SELL
$204.88 - $255.03 $5.68 Million - $7.06 Million
-27,700 Reduced 94.86%
1,500 $383,000
Q4 2020

Feb 12, 2021

BUY
$186.91 - $214.42 $2.07 Million - $2.38 Million
11,100 Added 61.33%
29,200 $5.94 Million
Q2 2020

Aug 14, 2020

BUY
$113.31 - $182.44 $1.03 Million - $1.66 Million
9,100 Added 101.11%
18,100 $3.01 Million
Q2 2019

Aug 14, 2019

BUY
$144.16 - $172.9 $1.3 Million - $1.56 Million
9,000 New
9,000 $1.56 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.